Lassa fever, which remains endemic in West Africa, typically surges during the dry season from December to April every year. […]
INTEGRATE Advances Lassa Fever Research with Phase 2 of ARN-75039 Trial in Nigeria Read More »
Members of the INTEGRATE consortium shared key scientific insights and presented updates on the clinical trial’s progress during the 2nd
AS INCLUSIONS FOR ITS CLINICAL TRIAL FOR A NEW LASSA FEVER TREATMENT PROGRESS, THE INTEGRATE CONSORTIUM CONTINUES TO STRENGTHEN STAFF
INTEGRATE CONSORTIUM BUILDS STAFF CAPACITY TO SUPPORT ONGOING CLINICAL TRIAL Read More »
In May 2025, the INTEGRATE clinical trial officially started first patient inclusions at one of West Africa’s leading Lassa Fever
